<DOC>
	<DOCNO>NCT02706249</DOCNO>
	<brief_summary>Hospitalized patient histologically cytologically confirm diagnosis solid tumor malignancy lymphoma high risk venous thromboembolisn randomize standard dose versus intermediate dose enoxaparin .</brief_summary>
	<brief_title>Study Of Weight-Based Versus Standard Dose Enoxaparin Thromboprophylaxis In High-Risk Hospitalized Cancer Patients</brief_title>
	<detailed_description>In phase II trial , high risk hospitalize cancer patient enrol randomized standard dose enoxaparin versus intermediate dose ( weight adjust ) enoxaparin thromboprophylaxis . Study subject administer enoxaparin hospitalization double-blinded manner . Following completion 14 day , study arm unblinded low extremity ultrasound perform standard dose enoxaparin arm order accurately determine overall cumulative incidence thrombosis group .</detailed_description>
	<criteria>Participants must histologically cytologically confirm diagnosis solid tumor malignancy lymphoma Anticipated hospitalization &gt; 72 hour . Received treatment ( chemotherapy radiotherapy ) malignancy within previous 6 month One Paduabased risk factor : History previous venous thromboembolic event ( exclude superficial vein thrombosis ) Reduced mobility ( ECOG performance status 3 4 , see Appendix A ) Established hereditary thrombophilia ( e.g . Factor V Leiden , G20210 prothrombin mutation , protein C S deficiency , antithrombin deficiency ) . Recent surgery within last 30 day Age ≥ 70 year Congestive heart failure ( NYHA class III IV ) Complicated respiratory insufficiency ( define increase requirement supplementary oxygen least 2L ) Acute myocardial infarction ischemic stroke Obesity ( BMI ≥ 30 ) Receiving hormonal agent ( e.g . tamoxifen , estrogen , testosterone ) Acute infection ( i.e . require antimicrobial therapy ) Age ≥ 18 year Life expectancy great 30 day Platelet count ≥ 100,000/mcL Creatinine &lt; 1.5 mg/dL estimate creatinine clearance ≥ 50 mL/min/1.73 m2 Ability understand willingness sign write informed consent document Weight 50kg 130 kg . History allergic reaction attribute heparin low molecular weight heparin Active bleeding otherwise consider high risk hemorrhage ( e.g . know acute gastrointestinal ulcer ) Any history significant hemorrhage ( require hospitalization transfusion ) within last 6 month ( exclude hemorrhage operative procedure ) . History heparin induce Thrombocytopenia Presence coagulopathy ( PT PTT &gt; 1.2 x upper limit normal ) Known diagnosis disseminate intravascular coagulation Currently receive therapeutic anticoagulant therapy dual antiplatelet therapy ( eg . aspirin clopidogrel ) Uncontrolled arterial hypertension ( systolic blood pressure &gt; 200mmHg , diastolic &gt; 110mmHg ) Active peptic ulcer disease Bacterial Endocardititis Received type Pharmacologic Thromboprophylaxis ( e.g . low molecular weight heparin heparin ) &gt; 48 hour current hospitalization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>